RT Book, Section
A1 Gruessner, Angelika C.
A1 Dunn, David L.
A1 Gruessner, Rainer W.G.
A2 Brunicardi, F. Charles
A2 Andersen, Dana K.
A2 Billiar, Timothy R.
A2 Dunn, David L.
A2 Kao, Lillian S.
A2 Hunter, John G.
A2 Matthews, Jeffrey B.
A2 Pollock, Raphael E.
SR Print(0)
ID 1175964387
T1 Transplantation
T2 Schwartz's Principles of Surgery, 11e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9781259835353
LK accessmedicine.mhmedical.com/content.aspx?aid=1175964387
RD 2024/04/25
AB Key  Points  The  field  of  transplantation  has  made  tremendous  advances  in  the  last  50  years,  mainly  due  to  refinements  in  surgical  technique  and  development  of  effective  immunosuppressive  medications.  Although  immunosuppressive  medications  are  essential  for  transplantation,  they  are  associated  with  significant  short-  and  long-term  morbidity.  Opportunistic  infections  can  be  significantly  lowered  by  the  use  of  appropriate  antimicrobial  agents.  Kidney  transplantation  represents  the  treatment  of  choice  for  almost  all  patients  with  end-stage  renal  disease.  The  gap  between  demand  (patients  on  the  waiting  list)  and  supply  (available  kidneys)  continues  to  widen.  Pancreas  transplantation  represents  the  most  reliable  way  to  achieve  euglycemia  in  patients  with  poorly  controlled  diabetes.  The  results  of  islet  transplantation  continue  to  improve  but  still  trail  those  of  pancreas  transplantation.  Liver  transplantation  has  become  the  standard  of  care  for  many  patients  with  end-stage  liver  failure  and/or  liver  cancer.